Photo of Dr Gargi Banerjee

Dr Gargi Banerjee

Email:

Location:

  • National Hospital for Neurology and Neurosurgery

GMC/GDC number:

7073633

Professional background

Dr Banerjee studied medicine at the University of Cambridge (pre-clinical) and the University of Oxford (clinical), qualifying in 2010. Her initial clinical training was in North West London; she obtained her MRCP in 2013 and completed her PhD in Clinical Neurology in 2019, at the Stroke Research Centre, UCL Queen Square Institute of Neurology.

Dr Banerjee started specialist training in neurology as an NIHR Academic Clinical Fellow (2018 to 2021), with clinical rotations at the National Hospital for Neurology and Neurosurgery, Queen Square, and Chelsea and Westminster Hospital. She continued specialist training as an NIHR Clinical Lecturer (2021 to 2025), with clinical rotations at the National Hospital for Neurology and Neurosurgery, Queen Square. She became a consultant neurologist in October 2025.

Specialties

Research interests

  • Cerebral amyloid angiopathy 
  • Iatrogenic amyloid-beta transmission 
  • The expanded prion paradigm 
  • Intracerebral haemorrhage 
  • Cerebral small vessel disease 

Publications

A full list of Dr Banerjee’s publications can be found here. 

Selected publications: 

  • Banerjee G, Mok TH, Hyare H, Cousins O, Jaunmuktane Z, Mead S, Collinge J. High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure. JAMA Neurol. 2026. doi: 10.1001/jamaneurol.2026.0437. 
  • Banerjee G, Farmer SF, Hyare H, Jaunmuktane Z, Mead S, Ryan NS, Schott JM, Werring DJ, Rudge P, Collinge J. Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormone. Nat Med. 2024. doi: 10.1038/s41591-023-02729-2. 
  • Fandler-Höfler S, Kaushik K, Storti B, Pikija S, Mallon D, Ambler G, Damavandi PT, Panteleienko L, Canavero I, van Walderveen MAA, van Etten ES, DiFrancesco JC, Enzinger C, Gattringer T, Bersano A, Wermer MJH, Banerjee G, Werring DJ. Clinical-radiological presentation and natural history of iatrogenic cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry. 2025. doi: 10.1136/jnnp-2024-335164. 
  • Banerjee G, Samra K, Adams ME, Jaunmuktane Z, Parry-Jones AR, Grieve J, Toma AK, Farmer SF, Sylvester R, Houlden H, Rudge P, Mead S, Brandner S, Schott JM, Collinge J, Werring DJ. Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon. J Neurol Neurosurg Psychiatry. 2022. doi: 10.1136/jnnp-2022-328792.  
  • Banerjee G, Adams ME, Jaunmuktane Z, Lammie GA, Turner B, Wani M, Sawhney IMS, Houlden H, Mead S, Brandner S, Werring DJ. Early-onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura. Ann Neurol. 2019. doi: 10.1002/ana.25407. 
  • Banerjee G, Collinge J, Fox NC, Lashley T, Mead S, Schott JM, Werring DJ, Ryan NS. Clinical considerations in early-onset cerebral amyloid angiopathy. Brain. 2023. doi: 10.1093/brain/awad193.